Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × Filgrastim × Clear all

NCT02774291 2023-08-04

Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes

Phase EARLY_PHASE1 Terminated

3 enrolled 6 charts

Brain Neoplasms, Neoplasm Metastasis

NCT01537861 2015-01-26

Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma

Phase EARLY_PHASE1 Terminated

Multiple Myeloma